Termination of very early pregnancy by vaginal suppositories-(15S)-15-Methyl prostaglandin F2a Methyl Ester
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 24 (6) , 603-615
- https://doi.org/10.1016/0010-7824(81)90012-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Self-administration of prostaglandin for termination of early pregnancyContraception, 1981
- Analysis of a study of menses induction using a vaginal suppository containing 3.0 mg 15(S)-15-methyl-PGF2α methyl esterContraception, 1980
- Early pregnancy interruption with two 15-ME-PGF2a suppositoriesContraception, 1980
- Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspirationContraception, 1979
- Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2α methyl ester vaginal suppositoryProstaglandins, 1978
- 15(S)15-Methyl protaglandin F2α for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositoriesProstaglandins, 1977
- Termination of early gestation with a vaginal polysiloxane device impregnated with (15S) -15 methyl prostaglandin F2a methylesterProstaglandins, 1977
- Evaluation of 15 (S)15 methyl-PGF2α methyl ester suppositories with a two dose schedule for termination of early pregnancyContraception, 1976
- Abortifacient efficiency of 15(S)15-methyl-prostaglandin F2α-methyl ester administered vaginally during early pregnancyProstaglandins, 1976
- TERMINATION BY PROSTAGLANDIN PELLETS IN VERY EARLY PREGNANCYThe Lancet, 1974